Childhood Supratentorial Neoplasm — Trials

Childhood Supratentorial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

35 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01236560	Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma	completed	Phase 2 / Phase 3	101	National Cancer Institute (NCI)NIH	2	Feb 20, 2024	clinicaltrials
NCT00679354	Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy	completed	Phase 2	30	National Cancer Institute (NCI)NIH	2	Aug 1, 2018	clinicaltrials
NCT00381797	Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma	completed	Phase 2	97	National Cancer Institute (NCI)NIH	1	Nov 28, 2017	clinicaltrials

Data updated 22 days agoSource updated Feb 20, 2024source: clinicaltrials